Equitable Holdings’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$233K Sell
833
-986
-54% -$259K ﹤0.01% 1647
2026
Q1
$485K Buy
+1,819
New +$493K ﹤0.01% 1266

Other funds holding LH

Equitable Holdings's LH Position: Q2 2026 in Review

Equitable Holdings reduced its Labcorp (LH) stake by 54% in Q2 2026, selling an estimated $259K and leaving 833 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Equitable Holdings first reported a position in LH in Q1 2026 and has held it in 2 quarters since. The position peaked at $485K in Q1 2026. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Equitable Holdings held 833 shares of Labcorp worth $233K as of Q2 2026.
  • Equitable Holdings sold 986 Labcorp shares in Q2 2026, an estimated $259K.
  • Labcorp made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1647 holding.
  • Equitable Holdings first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
  • Equitable Holdings's Labcorp position peaked at $485K in Q1 2026.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.